These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 10353759

  • 1. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
    Sigala S, Faraoni I, Botticini D, Paez-Pereda M, Missale C, Bonmassar E, Spano P.
    Clin Cancer Res; 1999 May; 5(5):1211-8. PubMed ID: 10353759
    [Abstract] [Full Text] [Related]

  • 2. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
    Bouras T, Frauman AG.
    J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
    [Abstract] [Full Text] [Related]

  • 3. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
    Xia W, Unger P, Miller L, Nelson J, Gelman IH.
    Cancer Res; 2001 Jul 15; 61(14):5644-51. PubMed ID: 11454719
    [Abstract] [Full Text] [Related]

  • 4. Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment.
    Sigala S, Bodei S, Missale C, Zani D, Simeone C, Cunico SC, Spano PF.
    Mol Cell Endocrinol; 2008 Mar 12; 284(1-2):11-20. PubMed ID: 18280641
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
    Tørring N, Jørgensen PE, Sørensen BS, Nexø E.
    Anticancer Res; 2000 Mar 12; 20(1A):91-5. PubMed ID: 10769639
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells.
    Yang X, Wei LL, Tang C, Slack R, Mueller S, Lippman ME.
    Cancer Res; 2001 Jul 01; 61(13):5284-8. PubMed ID: 11431371
    [Abstract] [Full Text] [Related]

  • 8. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
    Takaoka A, Hinoda Y, Satoh S, Adachi Y, Itoh F, Adachi M, Imai K.
    Oncogene; 1998 Mar 01; 16(11):1443-53. PubMed ID: 9525743
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
    Dong JT, Suzuki H, Pin SS, Bova GS, Schalken JA, Isaacs WB, Barrett JC, Isaacs JT.
    Cancer Res; 1996 Oct 01; 56(19):4387-90. PubMed ID: 8813131
    [Abstract] [Full Text] [Related]

  • 10. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
    Sekita N, Suzuki H, Ichikawa T, Kito H, Akakura K, Igarashi T, Nakayama T, Watanabe M, Shiraishi T, Toyota M, Yoshie O, Ito H.
    Jpn J Cancer Res; 2001 Sep 01; 92(9):947-51. PubMed ID: 11572762
    [Abstract] [Full Text] [Related]

  • 11. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
    Wu GJ, Peng Q, Fu P, Wang SW, Chiang CF, Dillehay DL, Wu MW.
    Gene; 2004 Mar 03; 327(2):201-13. PubMed ID: 14980717
    [Abstract] [Full Text] [Related]

  • 12. Reversion of human prostate tumorigenic growth by azatyrosine.
    Benoit RM, Eiseman J, Jacobs SC, Kyprianou N.
    Urology; 1995 Sep 03; 46(3):370-7. PubMed ID: 7660512
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism.
    Missale C, Losa M, Sigala S, Balsari A, Giovanelli M, Spano PF.
    Mol Endocrinol; 1996 Mar 03; 10(3):272-85. PubMed ID: 8833656
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
    White A, Lamb PW, Barrett JC.
    Oncogene; 1998 Jun 18; 16(24):3143-9. PubMed ID: 9671393
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
    Festuccia C, Muzi P, Gravina GL, Millimaggi D, Speca S, Dolo V, Ricevuto E, Vicentini C, Bologna M.
    Int J Oncol; 2007 Jan 18; 30(1):193-200. PubMed ID: 17143529
    [Abstract] [Full Text] [Related]

  • 20. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM.
    Cancer Res; 1999 May 01; 59(9):2203-9. PubMed ID: 10232609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.